Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07521137) titled 'Biweekly Long-term Occidiofungin Study for Suppression of Mycotic Recurrence' on April 2.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: Sano Chemicals Inc

Condition: Candidiasis, Vulvovaginal

Intervention: Drug: OCF001 Intravaginal Gel

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: April 20, 2026

Target Sample Size: 36

Countries of Recruitment: United States

To know more, visit https://clinicaltrials.gov/study/NCT07521137

P...